Please note this application is under active development. If you spot any errors or something isn't working, please contact us at evidence.service@wales.nhs.uk.

Tobacco: preventing uptake, promoting quitting and treating dependence: update [O] Evidence review for tailored interventions for those with mental health conditions

National Institute for Health and Care Excellence (2021)

NICE - ISBN: 978-1-4731-4347-0

Evidence Categories

  • Care setting: Healthcare Setting
  • Population group: Pre existing health condition
  • Intervention: Bupropian
  • Intervention: Multicomponent Interventions
  • Intervention: Electronic Nicotine Delivery System
  • Intervention: Behaviour Support
  • Intervention: Nicotine Replacement Therapy
  • Intervention: Varenicline
  • Outcome: Smoking cessation
  • Outcome: Changes to smoking rates

Type of Evidence

NICE Underpinning Review

Overview

Smoking prevalence is higher in those with mental health conditions and the decline of smoking in this group is at a much slower rate than in the general population. This is a group who are historically less likely to succeed in any quit attempt. Smoking cessation and harm reduction in this population is a key priority. This review aims to identify which tailored behavioural and pharmacotherapy interventions are most effective and cost effective, when compared with no intervention or usual care, at helping those with mental health conditions quit smoking or reduce their smoking.

Recommendations

This evidence review supports the research recommendation on support for people with mental health conditions to stop smoking. Other evidence supporting this recommendation can be found in the evidence reviews cessation and harm reduction treatments (review K).